GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SAFE (XPAR:ALSAF) » Definitions » Debt-to-Revenue

SAFE (XPAR:ALSAF) Debt-to-Revenue : 1.92 (As of Jun. 2022)


View and export this data going back to 2015. Start your Free Trial

What is SAFE Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

SAFE's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was €5.05 Mil. SAFE's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was €5.53 Mil. SAFE's annualized Revenue for the quarter that ended in Jun. 2022 was €5.52 Mil. SAFE's annualized Debt-to-Revenue for the quarter that ended in Jun. 2022 was 1.92.


SAFE Debt-to-Revenue Historical Data

The historical data trend for SAFE's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SAFE Debt-to-Revenue Chart

SAFE Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.67 1.42 1.38 2.48 1.94

SAFE Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.23 2.34 2.08 1.81 1.92

Competitive Comparison of SAFE's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, SAFE's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SAFE's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SAFE's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where SAFE's Debt-to-Revenue falls into.



SAFE Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

SAFE's Debt-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.579 + 5.281) / 4.561
=1.94

SAFE's annualized Debt-to-Revenue for the quarter that ended in Jun. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(5.053 + 5.527) / 5.52
=1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2022) Revenue data.


SAFE Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of SAFE's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SAFE (XPAR:ALSAF) Business Description

Traded in Other Exchanges
N/A
Address
Parc des Bellevues, Allee R. Luxemburg, Le Californie, Eragny sur Oise, FRA, 95610
SAFE, formerly SAFE Orthopaedics SA is engaged in the medical industry. The company manufactures implants used for spine correction surgeries.

SAFE (XPAR:ALSAF) Headlines

No Headlines